Document Detail


Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies.
MedLine Citation:
PMID:  25132967     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE: Myocardial infarctions constitute a major factor contributing to non-natural mortality world-wide. Clinical trials of myocardial regenerative therapy, currently pursued by cardiac surgeons, involve administration of stem cells into the hearts of patients suffering from myocardial infarctions. Unfortunately, surgical acquisition of these cells from bone marrow or heart is traumatic, retention of these cells to sites of therapeutic interventions is low, and directed differentiation of these cells in situ into cardiomyocytes is difficult. The specific aims of this work were: (1) to generate autologous, human, pluripotent, induced stem cells (ahiPSCs) from the peripheral blood of the patients suffering myocardial infarctions; (2) to bioengineer heterospecific antibodies (htAbs) and use them for recruitment of the ahiPSCs to infarcted myocardium; (3) to initiate in situ directed cardiomyogenesis of the ahiPSCs retained to infarcted myocardium.
METHODS: Peripheral blood was drawn from six patients scheduled for heart transplants. Mononuclear cells were isolated and reprogrammed, with plasmids carrying six genes (NANOG, POU5F1, SOX2, KLF4, LIN28A, MYC), to yield the ahiPSCs. Cardiac tissues were excised from the injured hearts of the patients, who received transplants during orthotopic surgery. These tissues were used to prepare in vitro models of stem cell therapy of infarcted myocardium. The htAbs were bioengineered, which simultaneously targeted receptors displayed on pluripotent stem cells (SSEA-4, SSEA-3, TRA-1-60, TRA-1-81) and proteins of myocardial sarcomeres (myosin, α-actinin, actin, titin). They were used to bridge the ahiPSCs to the infarcted myocardium. The retained ahiPSCs were directed with bone morphogenetic proteins and nicotinamides to differentiate towards myocardial lineage.
RESULTS: The patients' mononuclear cells were efficiently reprogrammed into the ahiPSCs. These ahiPSCs were administered to infarcted myocardium in in vitro models. They were recruited to and retained at the treated myocardium with higher efficacy and specificity, if were preceded with the htAbs, than with isotype antibodies or plain buffers. The retained cells differentiated into cardiomyocytes.
CONCLUSIONS: The proof of concept has been attained, for reprogramming the patients' blood mononuclear cells (PBMCs) into the ahiPSCs, recruiting these cells to infarcted myocardium, and initiating their cardiomyogenesis. This novel strategy is ready to support the ongoing clinical trials aimed at regeneration of infarcted myocardium.
Authors:
Marek Malecki; Emily Putzer; Chelsea Sabo; Afsoon Foorohar; Carol Quach; Chris Stampe; Michael Beauchaine; Raf Malecki; Xenia Tombokan; Mark Anderson
Related Documents :
19950097 - Left atrial myxoma with an atrial septal defect.
23934537 - Cxcr4(+) and flk-1(+) identify circulating cells associated with improved cardiac funct...
22421737 - Cardiac remodeling is not modulated by overexpression of muscle lim protein (mlp).
6822107 - Two dimensional echocardiography in the diagnosis of left ventricular thrombus. a prosp...
8553997 - Ultrasonic myocardial tissue characterization in patients with dilated cardiomyopathy: ...
5558187 - Acute myocardial infarction: home and hospital treatment.
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Molecular and cellular therapies     Volume:  2     ISSN:  2052-8426     ISO Abbreviation:  Mol Cell Ther     Publication Date:  2014 May 
Date Detail:
Created Date:  2014-8-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101624707     Medline TA:  Mol Cell Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Development of Superoxide Dismutase Mimetic Surfaces to Reduce Accumulation of Reactive Oxygen Speci...
Next Document:  Indications and outcomes in adult lung transplantation.